I guess I am fine with my position, although I’d probably add some on a serious pullback. But it just does not seem to stop. It is almost as if people think that the more intuitive interface for surgeons (haptic feedback & human vision guided camera) and better cost economics (business model that does not trap customers into a lifetime of technology/consumables from one company) might actually work to the company’s advantage in the still growing Robotic surgery space.
Okay, easy now. Only a few bots have been sold but in reading over the transcript of the company’s quarterly call, I like where it is heading. It seems as if others do too.
RBC has tagged it with $5 share price and liked what they heard in meetings with management. But I think the differentiators noted above are key.
Anyway, you’ve gotta have a couple story stocks in the portfolio, right? As of now the story is good as they install a few robots and continue to get good feedback.
I know painfully well that there once was another Robotic surgery company trading in the single digits that had a bright future. If I were to sell TRXC it would be like selling ISRG in the single digits, which it is my life-long shame to admit I did. I waited through thick and thin, paper gain and paper loss after buying this consolidation in anticipation of an outcome like this.
I know I am the dour macro geek guy, but I have a little casino patron in there somewhere and he’s enjoying this (but he knows that the going will get rough at some point).
Subscribe to NFTRH Premium for an in-depth weekly market report, interim updates and NFTRH+ chart and trade ideas. You can also keep up to date with plenty of actionable public content at NFTRH.com by using the email form on the right sidebar. Or follow via Twitter @BiiwiiNFTRH, StockTwits or RSS. Also check out the quality market writers at Biiwii.com.